Radioligand Therapeutic Agent
- Name
- Radioligand Therapeutic Agent
- Accession Number
- DBCAT005833
- Description
Not Available
- Drugs
Drug Drug Description Lutetium Lu-177 vipivotide tetraxetan A radioligand therapeutic agent used to treat prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer in adults. - Drugs & Drug Targets
Drug Target Type Lutetium Lu-177 vipivotide tetraxetan Prostate-specific antigen target